Advice
Following an abbreviated submission
Desmopressin 120 mcg oral lyophilisate (DesmoMelt) is accepted for use within NHS Scotland for the treatment of primary nocturnal enuresis.
At clinically equivalent doses there is no additional cost for the sublingual formulation compared with conventional tablets.
Download detailed advice28KB (PDF)
Medicine details
- Medicine name:
- desmopressin 120Â mcg oral lyophilisate (DesoMelt)
- SMC ID:
- 282/06
- Indication:
- Primary nocturnal enuresis
- Pharmaceutical company
- Ferring Pharmaceuticals Ltd
- BNF chapter
- Endocrine system
- Submission type
- Abbreviated
- Status
- Accepted
- Date advice published
- 10 July 2006